Global Interventional Oncology Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Embolization Devices, Ablation Devices, and Support Devices.

By Cancer Type;

Kidney, Lung, Breast, Liver, Bone Metastasis, and Others.

By Procedure;

Thermal Ablation, Non-Thermal Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization, and Transcatheter Arterial Embolization.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn207804667 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Interventional Oncology Market (USD Million), 2021 - 2031

In the year 2024, the Global Interventional Oncology Market was valued at USD 2,830.20 million. The size of this market is expected to increase to USD 4,695.44 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.

The Global Interventional Oncology Market encompasses a diverse array of medical devices and procedures designed to diagnose, treat, and manage various types of cancer through minimally invasive techniques. This market is experiencing significant growth driven by several factors, including technological advancements, increasing cancer incidence rates, and a shift towards less invasive treatment modalities.

Interventional oncology procedures involve the use of specialized devices such as ablation systems, embolization devices, and imaging technologies to precisely target and treat cancerous tumors. These procedures offer patients alternatives to traditional surgery, with benefits such as reduced recovery times, fewer complications, and improved quality of life.

One of the primary drivers of market growth is the rising incidence of cancer globally. As cancer rates continue to climb, there is a growing need for effective and less invasive treatment options that can be delivered with precision. Technological advancements in interventional oncology devices, such as improved imaging modalities and navigational systems, are enhancing the accuracy and safety of cancer treatments, further driving market expansion.

Geographically, North America and Europe currently dominate the interventional oncology market, owing to factors such as well-established healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investment in cancer research and treatment. However, emerging markets in Asia-Pacific and Latin America are also experiencing rapid growth, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness about the benefits of minimally invasive cancer treatments.

The Global Interventional Oncology Market is poised for continued growth as technological innovation continues to drive the development of more advanced and effective devices, and as healthcare systems worldwide increasingly recognize the value of minimally invasive approaches in cancer care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Cancer Type
    3. Market Snapshot, By Procedure
    4. Market Snapshot, By Region
  4. Global Interventional Oncology Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Incidence of Cancer
        2. Technological Advancements
        3. Growing Preference for Minimally Invasive Treatments
      2. Restraints
        1. Limited Awareness and Accessibility
        2. High Cost of Treatment
        3. Regulatory Challenges
      3. Opportunties
        1. Emerging Markets
        2. Personalized Medicine
        3. Collaboration and Integration
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Interventional Oncology Market, By Product, 2021 - 2031 (USD Million)
      1. Embolization Devices
      2. Ablation Devices
      3. Support Devices
    2. Global Interventional Oncology Market, By Cancer Type, 2021 - 2031 (USD Million)
      1. Kidney
      2. Lung
      3. Breast
      4. Liver
      5. Bone Metastasis
      6. Others
    3. Global Interventional Oncology Market, By Procedure, 2021 - 2031 (USD Million)
      1. Thermal Ablation
      2. Non-Thermal Ablation
      3. Transcatheter Arterial Chemoembolization
      4. Transcatheter Arterial Radioembolization
      5. Transcatheter Arterial Embolization
    4. Global Interventional Oncology Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Boston Scientific
      2. Terumo Corporation
      3. Medtronic
      4. BTG
      5. Ethicon
      6. AngioDynamics
      7. Merit Medical Systems
      8. Sirtex Medical
      9. Eckert & Ziegler
      10. BEBIG
  7. Analyst Views
  8. Future Outlook of the Market